The Italian Medical Contraception Society (SMIC) is requesting to the Ministry of Health and the national Medicines Agency that EC pills are mandatorily stocked in all pharmacies, in order to make them more accessible and reduce time to start of treatment; and that EC is covered by the national health system, and thus provided free of charged in, at least, public and publicly contracted health facilities.
To ECEC’s knowledge, in Italy and another 15 European Union counties, the full cost of EC is covered directly by the user (Austria, Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, Hungary, Latvia, Lithuania, Poland, Portugal, Romania, Slovakia, and Slovenia). Only 7 countries (Belgium, France, Germany, Ireland, the Netherlands, Spain, and the United Kingdom) have partial or full reimbursement or subsidy mechanisms to make EC pills available at a lower cost or free of charge. You can read more here.
December 5, 2017. The Council of Europe Commissioner for Human Rights, Nils Muižnieks, issued a set of recommendations addressed to States on how to better ensure women’s sexual and reproductive health and rights (SRHR) in Europe. Read the full report here.
The recommendations underscore that women’s sexual & reproductive rights are human rights, and that States have the duty to respect, protect and fulfil them. The recommendations to States include:
guaranteeing the affordability, availability and accessibility of modern contraception, including the removal of barriers that obstruct timely access to emergency contraception; and
ensuring that all survivors of sexual violence, including women in conflict zones or detention centres, victims of trafficking, asylum seekers and refugees, can access comprehensive sexual and reproductive health services, including emergency contraception.
The report provides an overview of State’s human rights obligations in this field and examples of shortcomings that European states must address in particular as regards women’s rights to life, health, privacy, equality, non-discrimination, as well as their right to be free from torture and ill-treatment.
September 2017. The delivery of EC by pharmacists is an important contribution to the promotion of sexual health and allows easier access to the method. When pharmacists have the necessary knowledge, the majority of emergency contraception issues can be resolved in the pharmacy, enabling the woman to take the most suitable EC method immediately on site. In some situations, however, referral to a specialised center or provider is needed.
July 2017. The British health retailer Superdrug (the second largest chain in the United Kingdom) announced on June 27th the sell of a generic levonorgestrel (LNG) emergency contraceptive pill, at less than half the price of the currently branded EC pills. Ezinelle will be sold at around 15,30 €, while currently the rest of LNG brands cost around 42 €.
In 2016, ECEC analysed the differences in the price being paid for EC pills when procured directly from pharmacies, across European Union countries. The highest prices were found in the United Kingdom and Ireland, where women pay over 40 € for levonorgestrel EC pills, and the lowest in France, at 7 € for the exact same product. Based on this data, the NGO British Pregnancy Advisory Service (Bpas), launched the Just Say Non campaign, to demand more affordable prices.
Congratulations to Bpas for the smart and fruitful campaign and for making EC more accessible to all women in the United Kingdom. More news from British media outlets here, here and here.
June 2017. On June 23rd President Andrzej Duda finally signed the bill proposed by the ruling party Law and Justice (PiS), which will change the status of the only EC pill currently available without prescription in Poland (EC with ulipristal acetate, sold under the brand name ellaOne).
The so called “Act of 25th May 2017 on the change in the Act on medical services financed from a state budget and some other acts” will enter into effect 30 days after signature (end of July). You can read more about the process in ASTRA’s website.
The Polish government has made an important legislative effort, investing a lot of time and public resources, to restrict access to a safe and effective contraceptive; to a drug that allows women and couples to have more control over their bodies and lives; to a drug that helps women realize their rights to health and life. We need to continue educating about emergency contraception, dispelling myths and misconceptions, and strive to ensure sure that EC programs and policies are based on evidence. We have a lot of work to do.
June 2017. A new survey and a web discussion have provided new data about whether and how Italian women’s awareness of and access to EC has changed following the availability of UPA EC without a prescription in 2015. According to this data, 90% of the women consulted consider EC useful and 91% think it is effective; but on the other hand, 54% think EC pills may be dangerous and only 20% know that the EC pills can be purchased without a prescription. Furthermore, only 2 out of 100 women know the basic differences between UPA and LNG EC pills, which may indicate a sever lack of awareness of their postcoital contraception choices. Doctors in Italy are asking the Ministry of Health to add EC to the list of drugs that are mandatory to have at a pharmacy as a means of preventing abortion. Please see here (in Italian and English) and here (in Italian) for more.
In order to raise awareness among the younger population, the Italian Medical Society for Contraception (SMIC) held a poster competition among students from various artistic high schools in Rome and Milan. The posters had to bring attention to different forms of contraception, including EC. The winning poster, seen at right, is titled “IL LATTICE CHE CI PIACE,” which translates to “The Latex That We Like” (condoms), and at the end of the poster is the text “And if the condom breaks? Remember: There is the pill of the next day,” referring to EC. The poster will be distributed to clubs and other youth-gathering sites throughout the summer. Please see here, here, here, and here (in Italian) for more information on the campaign and the SMIC.
This new guideline, which includes recommendations on LNG and UPA EC pills as well as on the use of IUD for EC, has been developed by the FSRH and brings together evidence and expert opinion on the provision of EC to women following unprotected or inadequately protected sexual intercourse. The guideline was developed with a team of experts in the relevant fields and has been extensively peer reviewed in accordance with methodology used for developing FSRH Clinical Guidelines. Part of their review process included a month-long open call for public consultation on the draft of their guideline. FSRH used a participatory and transparent process in updating their document and welcomed feedback from those outside of their organization.
May 29 2017. Since mid 2015, and upon recommendation from the European Medicines Agency, EC pills with ulipristal acetate can be bought without prescription from pharmacies in Poland and everywhere else in the European Union except for Hungary.
On May 25th, however, Members of Parliament in Poland voted in favor of a new bill which proposes, among other restrictions, to reinstate mandatory prescription to buy ulipristal acetate EC pills. Women’s reproductive rights are at stake again.